JUSTIN ARMOUR: Open Payments
NPI 1487493342 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 25 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $1,340 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $419 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| PFIZER INC. | 3 | $80 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| NS Pharma, Inc. | 1 | $18 |
Products named: QULIPTA, BOTOX, KESIMPTA, NURTEC ODT, UBRELVY, ULTOMIRIS, HYQVIA, VILTEPSO.
Industry payments across NV — which companies pay providers there.
